Washington D.C., Mar 31, 2016 / 11:02 am
The US Food and Drug Administration on Wednesday expanded its recommended use of the abortion drug mifepristone, drawing criticism from pro-life advocates who say it is harmful for women and their unborn babies, who may now be chemically aborted up to 10 weeks into pregnancy.
Mifepristone is combined with the drug misoprostol to induce an abortion. The FDA's March 30 policy change will allow the drug to be used up to 10 weeks into pregnancy instead of seven.
"The FDA has bowed to pressure from drug companies and abortion advocates, but the ones who will feel the deplorable effects of this change will be the women sent home to endure a painful and shocking process by themselves and of course their babies," Dr. Grazie Pozo Christie, a physician and advisory board member with The Catholic Association, said March 31.
Maureen Ferguson, senior policy advisor at The Catholic Association, also criticized the determination.